TL5: H0 P-value based futility decision and other seemingly inappropriate methods
Mridul Chowdhury, FDA/CBER  *Stan Lin, FDA/CBER 

Keywords: Futility analysis, decision, inappropriate

Our table proposes to talk about futility analysis and decision approaches in clinical trial protocols that appear seemingly inappropriate. Discussion and sharing of experience or thoughts are welcome.